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Electronic health records (EHR) might be a useful resource to study the risk factors and clini-
cal care of people with dementia. We sought to determine the diagnostic validity of dementia
captured in linked EHR.
Methods and findings
A cohort of adults in linked primary care, hospital, disease registry and mortality records in
England, [CALIBER (CArdiovascular disease research using LInked Bespoke studies and
Electronic health Records)]. The proportion of individuals with dementia, Alzheimer’s dis-
ease, vascular and rare dementia in each data source was determined. A comparison was
made of symptoms and care between people with dementia and age-, sex- and general
practice-matched controls, using conditional logistic regression. The lifetime risk and
prevalence of dementia and mortality rates in people with and without dementia were esti-
mated with random-effects Poisson models. There were 47,386 people with dementia:
12,633 with Alzheimer’s disease, 9540 with vascular and 1539 with rare dementia. Sev-
enty-four percent of cases had corroborating evidence of dementia. People with dementia
were more likely to live in a deprived area (conditional OR 1.26;95%CI:1.20–1.31 most
vs least deprived), have documented memory impairment (cOR = 11.97;95%CI:11.24–
12.75), falls (cOR = 2.36;95%CI:2.31–2.41), depression (cOR = 2.03; 95%CI:1.98–2.09)
or anxiety (cOR = 1.27; 95%CI:1.23–1.32). The lifetime risk of dementia at age 65 was
9.2% (95%CI:9.0%-9.4%), in men and 14.9% (95%CI:14.7%-15.1%) in women. The popu-
lation prevalence of recorded dementia increased from 0.3% in 2000 to 0.7% in 2010. A
higher mortality rate was observed in people with than without dementia (IRR = 1.56;95%
CI:1.54–1.58).
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Conclusions
Most people with a record of dementia in linked UK EHR had some corroborating evidence
for diagnosis. The estimated 10-year risk of dementia was higher than published population-
based estimations. EHR are therefore a promising source of data for dementia research.
Introduction
Dementia is a common progressive clinical syndrome that develops slowly over years. Many of
those affected are disabled not only by cognitive impairment but also by common co-morbidi-
ties of ageing such as stroke, arthritis, and heart disease. The burden of dementia on patients,
carers and the health system is substantial, and might increase as populations grow older.[1]
Very long follow-up is needed to study risk factors for dementia, because of the long pro-
drome before suspicion of diagnosis, reverse causality, and because it is likely that different
factors affect disease risk at different stages over a lifetime. This means that well conducted
prospective studies with complete follow-up are important, but they are rare and costly.[2,3]
More efficient methods to study dementia, on a large scale and with a low dropout rate, would
improve our understanding of the pathophysiology of this condition. National electronic
health records (EHR) linking primary care, hospital and death records are a potentially impor-
tant source of data for dementia research. They include people with the severest manifestations
of dementia or disability, who might be under-represented in bespoke recruited cohorts
because they are difficult to recruit or follow-up. They also capture a wide variety of important
health events. However, it is uncertain whether EHRs capture dementia with sufficient accu-
racy and completeness.
Studies of the validity of dementia in EHRs reported positive predictive values for a demen-
tia of up to 90% [4,5] (i.e. when a diagnosis is recorded, people usually have dementia). These
studies have relied on hand searching of individual clinical charts, and therefore had modest
sample sizes (<500). EHR might underestimate the proportion of people with dementia (i.e.
a low sensitivity) compared with bespoke cohorts. However, the longitudinal nature of elec-
tronic medical records provides multiple opportunities for capture of a dementia diagnosis,
and therefore measurement of the lifetime risk of dementia could provide a better measure of
the sensitivity of EHRs for dementia diagnosis.
In this study, we sought to determine how dementia is captured in different routinely
collected medical data sources; whether characteristic dementia symptoms might improve
dementia ascertainment; and to determine the lifetime risk of dementia from these records.
Methods
Study population
We studied a cohort of people registered in the Clinical Practice Research Datalink (CPRD)
general practices between 1st January 1998 and 31st March 2010. At study entry, eligible
patients were aged 18 or above at the beginning of the cohort and had at least one year of up-
to-standard pre-study follow-up. We used the CArdiovascular disease research using LInked
Bespoke studies and Electronic health Records (CALIBER) dataset that links individuals in
CPRD to national hospital admission and death records.[6] This linked dataset includes 4% of
the English population and is broadly representative of the UK population in terms of age, sex,
ethnicity and overall mortality.[7–9]
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PLOS ONE | https://doi.org/10.1371/journal.pone.0199026 June 26, 2018 2 / 12
Funding: CALIBER was funded by the Wellcome
Trust and The National Institute for Health
Research (NIHR) Programme Grants for Applied
Research programme (grant RP-PG-0407-10314)
to HH. WNW was funded for part of this study by
an MRC Clinician Scientist Fellowship (grant
G0902303) and by a CSO Scottish Senior
Fellowship Award (SCAF/17/01). The funders had
no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: This work uses data
provided by patients and collected by the NHS as
part of their care and support. The authors have no
competing interests.
Definition of dementia
We identified dementia in the three data sources using the clinical terms (Read version 2) (67
codes), ICD-9 (12 codes) and ICD-10 (36 codes) classification systems (Figure A and Table A
in S1 File). We defined dementia as the record of one or more diagnostic codes in any of the
three data sources at any time and in any position (i.e. dementia was any of the recorded diag-
nosis in hospital admission or death record). We defined people with corroborating evidence
of diagnosis if they had dementia with: (i) more than one record of dementia in the same data
source, on different dates; or (ii) a record of dementia in 2 or 3 data sources; or (iii) a record of
falls, confusion, memory problems or nursing home admission; or (iv) dementia monitoring
codes in primary care; or (v) a referral to a dementia speciality (geriatrics, care of the elderly,
psychiatry); or (v) more than one prescription of rivastigmine, galantamine, donepezil, mem-
antine, which are typically used to treat patients with Alzheimer’s disease and sometimes
patients with dementia in Parkinson’s disease and dementia with Lewy bodies. We additionally
classified people with dementia into four sub-types, Alzheimer’s disease, vascular, rare and
unclassified; using Read and ICD diagnostic codes. Rare dementia included fronto-temporal
dementia, dementia with Lewy bodies, Parkinson’s, Huntingdon’s, Pick’s or Creutzfeld-Jakob
diseases, and HIV-related dementia.
Selection of comparison group
For each case with dementia identified in primary or hospital care, we randomly selected up to
ten people without dementia (concurrent sampling), who were matched on sex, year of birth
and general practice. Controls had to be alive and actively registered in the general practice at
the date of diagnosis of the matched dementia case, and to have had a contact with the practice
within the year prior or after the matched index date. A total of 47151 people with dementia
(99.5% of the total identified) were matched. They were followed up until death, transfer out of
their primary care practice, or the date of administrative censoring (March 2010).
Statistical analysis
We described the frequency and proportion of people with dementia and its subtypes, in the
linked data and in each data source. We compared symptoms and management characteristics
of people with dementia in cases and matched controls using conditional logistic regression
that takes into account the matched structure of the data and consequently adjusts the results
for the matching factors. We measured deprivation with the index of multiple deprivation,
and divided the population into fifths based on this measure.[10] We calculated the 10-year
and lifetime risks of dementia and Alzheimer’s according to age and gender, using Kaplan-
Meier methods corrected for competing risk of death and using age as the time-scale. For this
analysis we included all registered patients who were alive, registered in the cohort and without
any dementia diagnosis, at the beginning of follow-up (i.e. earliest date of study eligibility), for
example at their 65th, 75th and 85th birthdays. Such follow-up then ended on the date of first
recorded dementia diagnosis (for cases) or the earliest of date of death, practice deregistration
or last data collection date in the practice. We then estimated the point-prevalence of dementia
in the entire cohort on 1st July 2000 and 2005 and on 1st January 2010. We counted as cases
also patients who were diagnosed with dementia only at death, when this happened within a
year from the analysis time points. Finally we compared overall and sex-specific mortality
rates ratios in people with and without dementia in the matched subset. We performed this
analysis using random-effects Poisson models, adjusted for age and sex as appropriate, with
age as the time-scale. Cox proportional hazard models were not used because the hazard ratio
Dementia in linked electronic medical records
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for mortality was not constant over time. For this analysis the observation period began on the
date of first recorded dementia diagnosis of the matched case.
All analyses were performed using Stata 13. The study was registered at www.clinicaltrials.
gov (NCT02549872). Approval was granted by the Independent Scientific Advisory Commit-
tee of the Medicines and Healthcare products regulatory agency (protocol no. 15_138).
Role of the funding source
The funding source had no role in the preparation of the manuscript.
Results
Diagnosis ascertainment and data source overlap
We identified 47,386 people with dementia, of whom 34,925 (74%) had corroborating evi-
dence to support their diagnosis (Figure B in S1 File). A total of 22,184 (47%) could be classi-
fied into a dementia subtype: 12,633 (27%) had Alzheimer’s disease, 9,540 (20%) had vascular
dementia and 1,539 (3%) had a rare dementia (Table B in S1 File). Compared to people with
unclassified dementia, a greater proportion of those with a specific dementia subtype had cor-
roborating evidence for their diagnosis (82% of Alzheimer’s disease, 71% of vascular, 69% of
rare and 62% of unclassified subtype).
Of the 47,386 cases of dementia, 55% were captured in primary care, 65% in hospital rec-
ords, and 26% in the national death register only (Table 1). Overall, 44% of dementia cases
were captured in hospital or in the mortality registry but not in primary care, and 23% were
captured in primary care records only (Fig 1). In each data source, most people had corrobo-
rating evidence of dementia (88% in primary care, 76% in hospital and 83% in the death regis-
try). Overall, the proportion of people with dementia who had corroborating evidence was
74%. Compared with other data sources, a higher proportion dementia cases captured in the
primary care were prescribed dementia medication (18% versus 11% in hospital or 9% in the
mortality registry), had recorded symptoms (27% versus 23% or 25%) and had evidence of
dementia monitoring (40% versus 22% or 22%) or of referral to a relevant speciality (12% ver-
sus 10% or 8%).
Overall, a minority of patients with dementia had a primary care record of memory
impairment, confusion or admission to nursing home (23%), a record of dementia monitoring
(27%) or had been referred to a geriatrician or care of the elderly psychiatrist (10%). Drugs typ-
ically indicated for Alzheimer’s dementia, dementia with Lewy bodies or dementia with Par-
kinson’s disease were more commonly prescribed to people with Alzheimer’s disease (27%) or
Table 1. Capture of diagnosis of dementia and overlap between data sources.
Dementia diagnosis All Primary care Hospital Mortality registry
No of people 47,386 26,269 31,034 12,232
No. of people with corroborating evidence 34,925 (74%) 23,225 (88%) 23,658 (76%) 10,191 (83%)
In multiple data sources 18,288 (39%) 15,348 (58%) 15,913 (51%) 9,176 (75%)
Multiple records in same data source 19,465 (41%) 8,770 (33%) 13,805 (44%) NA
Prescribed dementia medication 5,264 (12%) 4,438 (18%) 3,087 (11%) 1,001 (9%)
Dementia symptoms 11,066 (23%) 7,096 (27%) 7,008 (23%) 3,075 (25%)
Dementia monitoring in primary care 12,590 (27%) 10,537 (40%) 6,977 (22%) 2,664 (22%)
Referral to relevant speciality 4,509 (10%) 3,038 (12%) 3,031 (10%) 963 (8%)
Note: NA, non-applicable
https://doi.org/10.1371/journal.pone.0199026.t001
Dementia in linked electronic medical records
PLOS ONE | https://doi.org/10.1371/journal.pone.0199026 June 26, 2018 4 / 12
rare (26%) dementias than to people with vascular (6%) or with unclassified dementia subtype
(5%). Dementia subtypes were broadly consistently recorded across data sources, i.e. only 9%
of people with Alzheimer’s disease also had vascular codes, and only 12% of those with vascular
dementia also had Alzheimer’s codes; (Fig 2, Table B in S1 File).
There were 647 people with 2 or more prescriptions for dementia medication who had no
dementia diagnosis in any of the three data sources. The characteristics of this group were
similar to people identified with dementia i.e. 32% had dementia symptoms or nursing home
admission, 14% were monitored for dementia in primary care, and 14% had been referred to a
dementia relevant speciality.
Factors associated with dementia
At diagnosis, most people with dementia were over 80 years old; 3% were<60 years, 6% were
60–69 years, 25% were 70–79 years and 66% were>80 years (Table C in S1 File). Sixty-six
percent of them were women. Compared with matched controls, people with dementia were
more likely to live in a deprived area (conditional OR 1.26, 95%CI: 1.20–1.31 for most vs least
Fig 1. Capture of dementia in EHRs across the entire registration period in primary care, hospital episode statistics, and death records.
https://doi.org/10.1371/journal.pone.0199026.g001
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deprived; Table 2). They were also more likely to have record of memory impairment (condi-
tional OR 11.97, 95%CI:11.24–12.75), confusion (conditional OR 9.57, 95%CI:9.14–10.02),
falls (conditional OR 2.36 95%CI:2.31–2.41), depression (conditional OR 2.03, 95%CI:1.98–
2.09) or anxiety (conditional OR 1.27, 95%CI:1.23–1.32). Where a diagnosis of depression was
recorded, it was prior to dementia diagnosis in 71% of cases (5993/8449). People with demen-
tia more often had a recorded power of attorney (conditional OR 8.34, 95%CI: 7.24–9.61), or
had been admitted to a nursing home (conditional OR 7.09, 6.75–7.44).
However only a minority of people with a diagnosis of dementia had a record of any one of
these factors. The proportion of patients with dementia who had a missed a GP appointment
was similar to patients without dementia (28% vs 27%, OR 1.38, 1.11–1.16), and the annual
rate of GP consultation was similar in the two groups (proportions with>5 appointments per
year were 36% vs 56%). However, the annual hospital admission rate was higher in people
with than without dementia (proportions of>2 admissions per year were 3% vs <1%).
Prevalence of dementia
The prevalence of dementia increased markedly with age and over time, in both men and
women (Fig 3). In 2010, in men the prevalence was much higher over 90 (8.7%) than under
Fig 2. Capture of dementia by vascular dementia, Alzheimer’s dementia, rare dementia and dementia without specific diagnosis.
https://doi.org/10.1371/journal.pone.0199026.g002
Dementia in linked electronic medical records
PLOS ONE | https://doi.org/10.1371/journal.pone.0199026 June 26, 2018 6 / 12
Table 2. Characteristics of people with dementia compared with age-, practice- and sex-matched controls.
People with dementia People without dementia Adjusted conditional OR (95%CI)
N = 47,151 N = 324,627
Index of multiple deprivation (fifths)
1 (least) 10,741 (23%) 77,516 (24%) 1
2 10,860 (23%) 76,460 (24%) 1.05 (1.0–1.09)
3 9,986 (21%) 66,982 (21%) 1.12 (1.08–1.16)
4 8,440 (18%) 58,978 (18%) 1.12 (1.08–1.16)
5 (most) 7,124 (15%) 44,691 (14%) 1.26 (1.20–1.31)
Memory impairment
Yes 2,769 (6%) 1,842 (1%) 11.97 (11.24–12.75)
No 47,382 (94%) 322,785 (99%) 1
Confusion
Yes 4,829 (10%) 3,844 (1%) 9.57 (9.14–10.02)
No 42,322 (90%) 320,783 (99%) 1
Falls
Yes 18,673 (40%) 67,268 (21%) 2.36 (2.31–2.41)
No 28,478 (60%) 257,359 (79%) 1
Depression
Yes 8,449 (18%) 31,946 (10%) 2.03 (1.98–2.09)
No 38,702 (82%) 292,681 (90%) 1
Anxiety
Yes 4,262 (9%) 24,046 (7%) 1.27 (1.23–1.32)
No 42,889 (91%) 300,581 (93%) 1
Admission to nursing home
Yes 4,447 (9%) 4,868 (1%) 7.09 (6.75–7.44)
No 42,704 (91%) 319,759 (99%) 1
Power of attorney
Yes 459 (1%) 362 (<1%) 8.34 (7.24–9.61)
No 46,692 (99%) 324,265 (>99%) 1
Missed appointments
Yes 13,095 (28%) 87,548 (27%) 1.38 (1.11–1.16)
No 34,056 (72%) 237,079 (73%) 1
Median (IQR)1 1 (1–3) 1 (1–2)
GP consultation rate2
Missing 526 (1%) 0 (0%)
0 23,993 (51%) 19,637 (6%) 1
0–5 5,564 (12%) 123,302 (38%) 0.04 (0.04–0.04)
>5 17,068 (36%) 181,688 (56%) 0.07 (0.07–0.07)
Hospital admission rate2
Missing
0 526 (1%) 0 (0%)
0–1 16,828 (36%) 161,866 (50%) 1
1–2 28,412 (60%) 161,934 (50%) 1.67 (1.63–1.71)
>2 1,385 (3%) 827 (<1%) 15.15 (13.83–16.59)
1Amongst people with at least one missed appointment;
2Annual rate in the 5 years prior to entry
https://doi.org/10.1371/journal.pone.0199026.t002
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50 years (0.2%) (Table C in S1 File). The estimates were substantially higher in women than
in men in the eldest age group (14.2% vs. 8.7% in 2010). The prevalence of dementia gradu-
ally increased over time in men and women of all ages, for almost all dementia subtypes
(Figure C in S1 File) and for diagnosis captured in primary and hospital records (Figure D in
S1 File).
Lifetime risks of dementia
Estimates of lifetime risk of dementia and Alzheimer’s disease are shown in Table 3. The life-
time risk of dementia in women increased modestly with age, from 14.9% (95%CI 14.7%-
15.1%) at 65 years to 21.8% (95%CI 21.3%-22.3%) at 85 years. Lower estimates were found in
men: 9.2% (95%CI 9.0%-9.4%) at 65 years, and 15.4% (95%CI 14.7%-16.0%) at 85 years.
Fig 3. Time trends in prevalence of dementia according to age group and sex. Point prevalence estimated on 1st July
2000 and 2005 and 1st January 2010.
https://doi.org/10.1371/journal.pone.0199026.g003
Table 3. Lifetime risk of dementia in men and women estimated in linked primary care, hospital episode and death records.
All dementia Alzheimer’s disease
No. of people at risk 10-year risk in % Lifetime risk in % No. of people at risk 10-year risk in % Lifetime risk in %
Women
65 years 321,851 2.8 (2.7–2.9) 14.9 (14.7–15.1) 321,851 1.0 (0.9–1.1) 4.9 (4.7–5.0)
75 years 197,918 16.6 (16.3–16.8) 21.7 (21.4–21.9) 197,918 5.0 (4.8–5.1) 6.2 (6.0–6.3)
85 years 83,694 23.8 (23.3–24.3) 21.8 (21.3–22.3) 83,694 4.5 (4.2–4.7) 4.1 (3.9–4.4)
Men
65 years 253,203 2.7 (2.6–2.8) 9.2 (9.0–9.4) 253,203 0.7 (0.7–0.8) 2.5 (2.4–2.6)
75 years 128,957 12.8 (12.6–13.1) 14.5 (14.2–14.7) 128,957 3.4 (3.2–3.5) 3.7 (3.5–3.8)
85 years 38,822 17.4 (16.7–18.2) 15.4 (14.7–16.0) 38,822 3.5 (3.1–3.8) 3.2 (2.9–3.5)
Note:
() Lifetime risk calculated on the median residual life from the UK National Lifetable. For women aged 65, 75 and 85 the median years of residual life expectancy were
21.04, 13.11 and 6.81 years respectively, whereas for men aged 65, 75 and 85 they were 18.61, 11.35 and 5.85 years respectively.
https://doi.org/10.1371/journal.pone.0199026.t003
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Mortality associated with dementia
In total, 159,674 deaths were recorded during a median follow-up of 1.7 years (inter-quartile
range 0.6 to 3.4), 34,528 amongst people with dementia and 125,146 amongst those without
dementia (Table 4). The incidence rate ratio of mortality for people with dementia compared
to individuals without the disease was 1.56 (95% CI:1.54–1.58). Estimates were similar in men
and in women.
Discussion
Using contemporary, nationally-representative linked primary care, hospital records and
the death registry from 2,524,144 people in England and Wales, we identified people with
recorded diagnostic codes of dementia and dementia subtypes. The large majority of people
with dementia had corroborating evidence of diagnosis, including recording of multiple diag-
nostic records in one or more data sources, symptoms and care features characteristics of
dementia or were prescribed dementia medication. The lifetime risk of dementia at 65 years
was 15% in women and 9% in men, and mortality was 1.56 higher in people with than without
dementia.
Our findings highlight the importance of using multiple linked data sources for defining
dementia in EHRs. No individual data source analysed had complete coverage of coded
dementia. Six percent were only recorded in the death registry, thirty-two percent only in hos-
pital records and twenty-three percent only in primary care. Because data in CALIBER were
anonymised, we could not validate dementia cases against patient clinical charts.
However, subgroups of dementia codes have been validated in previous EHR-based studies.
[4,5,11,12] In addition, our estimated dementia lifetime risks are similar to figures reported in
previous population based cohort studies.[13] Our study suggests that Read-coded symptoms
on their own, cannot be used to identify unrecorded patients with dementia, because these are
infrequently recorded and are insufficiently specific, even in combination, to accurately iden-
tify cases. Future work with natural language processing methods of free text collected during
the consultation would be needed to make better use of symptom data in electronic records.
In studies based on the analysis of EHRs, lifetime risk of dementia is likely to be a more
suitable measure of disease risk than absolute incidence rates, given that the time of onset
of dementia is difficult to define in clinical practice. Lifetime risk is probably the most impor-
tant statistic for an individual when planning their future needs. The lifetime risk of dementia
Table 4. Association between dementia and mortality.
No. of people No. of deaths IRR (95% CI)
Overall
People without dementia 324,627 125,146 1
People with dementia 47,151 34,528 1.56 (1.54–1.58)
Men
People without dementia 132,251 51,882 1
People with dementia 16,088 11,982 1.61 (1.58–1.64)
Women
People without dementia 192,376 73,264 1
People with dementia 31,063 22,546 1.53 (1.51–1.56)
Note: IRR, incidence rate ratios adjusted for age and sex (as appropriate) from random-effects Poisson models
comparing people with dementia and randomly selected people without dementia matched for age, sex and general
practice
https://doi.org/10.1371/journal.pone.0199026.t004
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depends on the duration of life, and is affected by the competing risks of death from other
causes and the incidence of dementia in a population. We compared the 10 year risk of demen-
tia from the Framingham study [14] with our estimates (Table E in S1 File). Our lifetime risk
estimates were slightly higher than those reported in the US in 2005. For example, the 10 year
risks of all dementia found in the Framingham study at 75 in men was 7.6%, and in women
7.4%, as compared with 12.8% and 16.6% in our study.
The prevalence of dementia at different ages in this study in England was lower than esti-
mates reported in a community prevalence study with participants recruited from Cambridge-
shire, Liverpool and Newcastle. In that study in 2001, prevalences from age 65–69, 70–74, 75–
79, 80–84, 85–90 and over 90 in men were: 1.2, 3.0, 5.2, 10.6, 12.8, 17.1% and in women 1.8,
2.5, 6.2, 9.5, 18.1, and 35%. Our prevalence estimates were approximately half of this in 2000,
but about two-thirds of this in 2010, perhaps indicating improvement in recording. Commu-
nity based incidence studies using formal instruments are likely to ascertain dementia with a
lower severity, and it is possible that those in the EHRs represent only those in a later stage of
illness, those with clinically evident dementia [15] or with more severe symptoms.[12] Given
that the benefits of early dementia diagnosis have not been shown, and that the impact that
such diagnosis has on patients and their relatives, GPs may hesitate to formally diagnose the
disease until symptoms become disabling.
Although we have examined UK linked EHR from 1998 to 2010, our conclusions may not
be transportable to other EHR datasets covering different time periods. With changing UK
practice, diagnostic validity of a dementia record may change, with better ascertainment
achieved in recent years after a significant effort to improve dementia diagnosis in primary
care. Our results are not generalizable to other health systems, and therefore researchers work-
ing with data from these systems should aim to determine the validity of dementia diagnosis,
either by linking and/or comparing information from existing or new disease cohorts to their
EHR data sources, though case review, or conducting a similar analysis to ours.[16]
Although linked EHR are an efficient source of data for dementia research, there are a
number of weakness to be considered. First, there may be variation in case ascertainment and
validity of diagnosis across regions, depending on hospital or primary care diagnostic or man-
agement behaviours. Second, under ascertainment of diagnosis during the early stages of the
condition is likely- hence our recommendation for a lifetime approach. Finally, there is often
limited data on important prognostic factors, such as education and family history or APOE4
allele, although these might eventually be obtained through linkage to other data sources.
Conclusion
This study provides evidence that the diagnosis of dementia in linked electronic health records
has sufficient validity for large scale epidemiological studies. The major value of current rec-
ords is found in coded diagnoses, rather than additional symptoms or other care episodes,
which are seldom recorded. Despite reasonable concerns that that electronic health records
underestimate the point prevalence of dementia compared to research studies, the calculated
lifetime risk of dementia from these electronic health records is similar to population based
estimates.
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